Boston Scientific Corp’s recently made public that its Officer JOSEPH M FITZGERALD acquired Company’s shares for reported $5.27 million on Sep 02 ’25. In the deal valued at $105.43 per share,50,000 shares were bought.
Then, Fitzgerald Joseph Michael sold 50,000 shares, generating $5,231,670 in total proceeds. Upon selling the shares at $104.63, the EVP & Group Pres, Cardiology now owns 178,342 shares.
Before that, Butcher Arthur C sold 17,313 shares. Boston Scientific Corp shares valued at $1,811,520 were divested by the EVP& Grp Pres, MedSurg & APAC at a price of $104.63 per share. As a result of the transaction, Butcher Arthur C now holds 23,600 shares, worth roughly $2.52 million.
Leerink Partners initiated its Boston Scientific Corp [BSX] rating to an Outperform in a research note published on June 16, 2025; the price target was $118. A number of analysts have revised their coverage, including Needham’s analysts, who increased its forecast for the stock in mid April from “a Hold” to “a Buy”. Deutsche Bank also remained covering BSX and has increased its forecast on January 10, 2025 with a “Buy” recommendation from previously “Hold” rating. Needham revised its rating on October 18, 2024. It rated BSX as “a Hold” which previously was an “a Buy”.
Price Performance Review of BSX
On Tuesday, Boston Scientific Corp [NYSE:BSX] saw its stock jump 1.10% to $106.66. Over the last five days, the stock has gained 1.47%. Boston Scientific Corp shares have risen nearly 34.13% since the year began. Nevertheless, the stocks have risen 19.41% over the past one year. While a 52-week high of $108.94 was reached on 07/23/25, a 52-week low of $80.50 was recorded on 04/07/25.
Levels Of Support And Resistance For BSX Stock
The 24-hour chart illustrates a support level at 104.98, which if violated will result in even more drops to 103.29. On the upside, there is a resistance level at 107.61. A further resistance level may holdings at 108.55.
How much short interest is there in Boston Scientific Corp?
A steep rise in short interest was recorded in Boston Scientific Corp stocks on 2025-08-15, dropping by -0.97 million shares to a total of 18.6 million shares. Yahoo Finance data shows the prior-month short interest on 2025-07-15 was 19.57 million shares. There was a decline of -5.19%, which implies that there is a negative sentiment for the stock.
The most recent change occurred on May 30, 2024 when Goldman began covering the stock and recommended ‘”a Buy”‘ rating along with a $90 price target.
